Digital Twin Meets General Cargo Logistics
The logistics industry urgently needs digital transformation to ensure quality and to tackle challenges such as the shortage of skilled workers and sustainability.
Artificial Intelligence (AI)
Partex and Sanofi Partner for AI-Enhanced Dossier Improvement
Partex Group, an AI-driven drug discovery company, today announces a collaboration with global pharmaceutical company Sanofi, aimed at using Partex’s AI technology to enhance the value of Sanofi's out-licensing portfolio.
Iktos and Bayer Cooperate on Use of AI to Design Crop Protection Products
Iktos, a French company specialized in artificial intelligence (AI) for new drug design, and Bayer’s Crop Science division announced a collaboration to expand the use of AI in the discovery and development of new sustainable crop protection products.
Accelerate Chemical and Material Development
Process manufacturing companies waste almost $100 billion globally every year while formulating novel materials and chemicals due to the trial-and-error approach to R&D and the lack of tools to leverage the experimental data in real-time.
Making Lab Automation Actually Work
Manual experiment monitoring and data capture is still the status quo in most biotech and pharma labs, compromising efficiency and project timescales. But there is a better way.
Accelerating Chemicals Innovation
The Spanish computational chemistry start-up Nextmol (Bytelab Solutions), a spin-off from the Barcelona Supercomputing Centre, offers a software-as-a-service (SaaS) platform that accelerates research and innovation in sustainable specialty chemicals through “in silico” experiments using molecular modeling and artificial intelligence (AI).
CPHI Annual Report on Pharmaceutical Industry
The 7th edition of the CPHI Annual Survey was unveiled today highlighting trends for 2024. A total of 250 pharmaceutical executives were surveyed with 35 probing questions, with their answers informing the industry landscape for the next year, spanning all major pharma markets.
AstraZeneca Granted Global Starmap AI License for Nanoform
Nanoform, a nanoparticle medical technology company, has awarded AstraZeneca a global online STARMAP license. STARMAP is an AI-based digital rendition of CESS technology, facilitating in-silico experiments for selecting molecules to be nanoformed. This license enables AstraZeneca to screen molecules during the entire drug development process.
AstraZeneca, SAS Team up on AI and Analytics in Clinical Trials
AI and analytics software company SAS is collaborating with global biopharmaceutical company AstraZeneca to increase efficiency and drive automation in the delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities.
Providing Solutions by Making the Most of Biomedical Data
Many life science companies generate large swathes of data.
Creating added value through innovation and transformation
As a global specialty chemicals company, Altana develops innovative technologies, solutions, and products with a clear customer focus. The company aims to strengthen and expand this position in the long term. The topic of digital transformation plays a key role.
Creating added value through innovation and transformation
As a global specialty chemicals company, Altana develops innovative technologies, solutions, and products with a clear customer focus. The company aims to strengthen and expand this position in the long term. The topic of digital transformation plays a key role.
BioNTech to Acquire all of InstaDeep
As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to acquire all of London-based artificial intelligence specialist InstaDeep.
Sanofi Enters Research Pact with Hong Kong’s Insilico
French pharma Sanofi has entered a multi-year, multi-target research collaboration worth up to $1.2 billion with Hong Kong biotech Insilico Medicine.
AI Maturity Model for GxP Application
Artificial intelligence (AI) has become one of the supporting pillars for digitalization in many areas of the business world. The pharmaceutical industry and its GxP-regulated areas also want to use AI in a beneficial way, but only a small fraction of companies follows a systematic approach for the digitalization of their operations and validation. However, the assurance of integrity and quality of outputs via computerized system validation is essential for applications in GxP environments.
AI Makes Drug Discovery Faster
Interview with Joachim Haupt and Florian Kaiser, PharmAI
Sanofi to Tap Owkin’s AI for Oncology Pipeline
French drugmaker Sanofi is taking an equity stake worth $180 million in and entering a new strategic collaboration with artificial intelligence (AI) and precision medicine specialist Owkin.
Digital Transformation and Smart Manufacturing
Andreas Helget, Managing Director of Yokogawa Germany, about the importance of digital transformation on the way to autonomous systems.
Accelerated Drug Discovery
In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.
Will BASF Turn to Pig Farming? Not quite, but …
Why BASF Venture Capital is investing in SmartAHC, a supplier of digitalization solutions for pig farming on the Chinese market.
Creating the AI-Powered Future of Chemistry
Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.
